September 20, 2022
17:18
–
Researchers from UZ Brussels followed nearly 300 patients whose metastatic melanoma was treated with immunotherapy for twelve years. “A lot of research is still needed before we can offer everyone the prospect of a cure.”
–
About 8% of all skin cancers are melanomas. Until recently, this more aggressive form was always fatal once the cancer had spread. Since 2010, this type of skin cancer can be treated with immunotherapy in our country. This gives the immune system a boost to target and clear cancer cells.
–
The essence
- A study by UZ Brussel shows that a quarter of nearly 300 patients with metastatic melanoma recover five years after starting treatment.
- Patients are treated with immunotherapy, which gives the immune system a boost to target and clear cancer cells.
–
–
When the new therapy was introduced, researchers from UZ Brussels started a study to find out what the outcome was for patients. They followed 292 patients who were treated with anti-PD-1 antibody therapy.
–
‘In melanomas, the cancer cells are not clearly visible to the immune system,’ says Professor Bart Neyns, head of medical oncology at UZ Brussels who led the research. “Immunotherapy removes this by giving the immune system a clear path to attack cancer cells.”
–
Of the patients treated with classical chemotherapy ten years ago, less than 10 percent were still alive after five years.